Stratec SEXTER:SBS +4.76%62 Market Cap is €213.9 Mil as of Jul. 02, 2026. GuruFocus rates XTER:SBS with a GF Score™ of 62/100 and a GF Value™ of €32.26 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 869 Medical Devices & Instruments companies, Stratec SE ranks better than 58.92% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Stratec SE's share price for the quarter that ended in Mar. 2026 was €17.1. Stratec SE's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 12.2 Mil. Therefore, Stratec SE's market cap for the quarter that ended in Mar. 2026 was €207.9 Mil.
Stratec SE's quarterly market cap
declined
from Sep. 2025 (€348.3 Mil) to Dec. 2025 (€272.9 Mil) and
declined
from Dec. 2025 (€272.9 Mil) to Mar. 2026 (€207.9 Mil).
Stratec SE's annual market cap
declined
from Dec. 2023 (€553.7 Mil) to Dec. 2024 (€362.2 Mil) and
declined
from Dec. 2024 (€362.2 Mil) to Dec. 2025 (€272.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Stratec SE's Enterprise Value for Today is €321.7 Mil.
Stratec SE (XTER:SBS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Stratec SE Market Cap Related Terms
Stratec SE Market Cap Historical Data
* Premium members only.
The historical data trend for Stratec SE's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Stratec SE's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stratec SE Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's Market Cap distribution charts can be found below:
* The bar in red indicates where Stratec SE's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Stratec SE's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stratec SE (XTER:SBS) has a Market Cap of €213.9 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Stratec SE and its competitors. According to the industry distribution chart, Stratec SE ranks #357 out of 869 companies in the Medical Devices & Instruments industry, placing it in the top 41.1%.
Is Stratec SE's Market Cap too high?
Stratec SE's current Market Cap is €213.9 Mil. Based on the distribution chart, Stratec SE ranks #357 out of 869 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Stratec SE has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stratec SE's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Stratec SE ranks #357 out of 869 companies for Market Cap. This puts Stratec SE in the upper half of its industry. The industry median Market Cap is 119.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 119.28, based on 869 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Stratec SE and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 119.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stratec SE's current Market Cap is €213.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stratec SE stock overvalued right now?
Based on GuruFocus' analysis, Stratec SE (XTER:SBS) is currently considered Significantly Undervalued. The stock's GF Value™ is €32.26, compared to a current price of €17.60 — trading 45.4% below its estimated fair value. The current Market Cap is €213.9 Mil. Stratec SE's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Stratec SE (XTER:SBS), the current Market Cap is €213.9 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stratec SE (XTER:SBS) Overvalued in 2026?
Based on GuruFocus' analysis, Stratec SE stock appears to be undervalued.
The current stock price of €17.60 is trading 45.4% below its estimated GF Value™ of €32.26.
GuruFocus considers Stratec SE to be Significantly Undervalued.
Key valuation signals for XTER:SBS:
Market Cap: €213.9 Mil
GF Value™: €32.26 vs. price of €17.60 (45.4% below fair value)
No single metric tells the full story. See the XTER:SBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stratec SE designs and manufactures automation solutions for regulated laboratory markets. STRATEC acts as an OEM partner to players in the in-vitro diagnostics and life sciences markets. The Group's product range includes both hardware solutions, software solutions, and related consumables, as well as independently marketed consumables. These products are mostly combined into fully integrated system solutions and often receive market approval together with partners' reagents.
62GF Score
Get the complete analysis for XTER:SBS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:SBS has been successfully added to your 
